Automated description from the Alliance of Genome Resources (Release 3.1.1)
Predicted to have chaperone binding activity; insulin receptor binding activity; and protease binding activity. Predicted to be involved in several processes, including glucose homeostasis; positive regulation of protein phosphorylation; and regulation of gene expression. Localizes to cytosol. Predicted to colocalize with cytoplasm. Is expressed in several structures, including gut; trunk; and yolk sac. Used to study type 1 diabetes mellitus. Human ortholog(s) of this gene implicated in diabetic retinopathy; glucose metabolism disease (multiple); insulinoma; and pancreatic cancer. Orthologous to several human genes including INS (insulin).